Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 156 articles:
HTML format
Text format



Single Articles


    November 2018
  1. JUTTUKONDA MR, Franco G, Englot DJ, Lin YC, et al
    White matter differences between essential tremor and Parkinson disease.
    Neurology. 2018 Nov 30. pii: WNL.0000000000006694.
    PubMed     Text format     Abstract available


  2. KIM R, Lee J, Kim HJ, Kim A, et al
    CSF beta-amyloid42 and risk of freezing of gait in early Parkinson disease.
    Neurology. 2018 Nov 30. pii: WNL.0000000000006692.
    PubMed     Text format     Abstract available


  3. KARCESKI S
    Parkinson disease and mortality: Understanding how the two are connected.
    Neurology. 2018;91:e2106-e2108.
    PubMed     Text format    


  4. KOO BB
    Author response: Demoralization in Parkinson disease.
    Neurology. 2018;91:1030.
    PubMed     Text format    


  5. BRUNO V, Mancini D, Zurowski M, Miyasaki JM, et al
    Reader response: Demoralization in Parkinson disease.
    Neurology. 2018;91:1029.
    PubMed     Text format    


  6. GANESH A, Galetta S
    Editors' note: Demoralization in Parkinson disease.
    Neurology. 2018;91:1029.
    PubMed     Text format    


  7. BLEDSOE IO, Stebbins GT, Merkitch D, Goldman JG, et al
    White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease.
    Neurology. 2018 Nov 14. pii: WNL.0000000000006646.
    PubMed     Text format     Abstract available


  8. TURCANO P, Mielke MM, Bower JH, Parisi JE, et al
    Levodopa-induced dyskinesia in Parkinson disease: A population-based cohort study.
    Neurology. 2018 Nov 7. pii: WNL.0000000000006643.
    PubMed     Text format     Abstract available


    October 2018
  9. GOLBE LI, Leyton CE
    Life expectancy in Parkinson disease.
    Neurology. 2018 Oct 31. pii: WNL.0000000000006560.
    PubMed     Text format    


  10. BACKSTROM D, Granasen G, Domellof ME, Linder J, et al
    Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
    Neurology. 2018 Oct 31. pii: WNL.0000000000006576.
    PubMed     Text format     Abstract available


  11. FERRAYE MU
    Author response: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:811.
    PubMed     Text format    


  12. VAN GERPEN JA, Tipton PW, Uitti RJ
    Reader response: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:810-811.
    PubMed     Text format    


  13. KARAM C, Galetta S
    Editors' note: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:810.
    PubMed     Text format    


  14. HELMICH RC, Hallett M, Dirkx MF
    Author response: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:724.
    PubMed     Text format    


  15. JANKOVIC J
    Reader response: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:723.
    PubMed     Text format    


  16. KARAM C, Galetta S
    Editors' note: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:722.
    PubMed     Text format    


  17. GERAEDTS VJ, Boon LI, Marinus J, Gouw AA, et al
    Clinical correlates of quantitative EEG in Parkinson disease: A systematic review.
    Neurology. 2018 Oct 5. pii: WNL.0000000000006473.
    PubMed     Text format     Abstract available


    September 2018
  18. MORENO GM, Gandhi R, Lessig SL, Wright B, et al
    Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine.
    Neurology. 2018 Sep 26. pii: WNL.0000000000006396.
    PubMed     Text format    


    August 2018
  19. SPERLING SA, Shah BB, Barrett MJ, Bond AE, et al
    Focused ultrasound thalamotomy in Parkinson disease: Nonmotor outcomes and quality of life.
    Neurology. 2018 Aug 29. pii: WNL.0000000000006279.
    PubMed     Text format     Abstract available


  20. ADAMS JL, La Morgia C
    The search for Parkinson disease biomarkers: Retinal thinning as a correlate of dopamine loss.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006148.
    PubMed     Text format    


  21. AHN J, Lee JY, Kim TW, Yoon EJ, et al
    Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006157.
    PubMed     Text format     Abstract available


  22. KLEPITSKAYA O, Liu Y, Sharma S, Sillau SH, et al
    Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006162.
    PubMed     Text format     Abstract available


  23. PAGANO G, De Micco R, Yousaf T, Wilson H, et al
    REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
    Neurology. 2018 Aug 8. pii: WNL.0000000000006134.
    PubMed     Text format     Abstract available


  24. MACLEOD AD, Myint PK, Counsell CE
    Author response: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:287.
    PubMed     Text format    


  25. MARINELLI L
    Reader response: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:286.
    PubMed     Text format    


  26. ALCAUSKAS M, Galetta S
    Editors' note: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:286.
    PubMed     Text format    


  27. THOMPSON T, Poulter D, Miles C, Solmi M, et al
    Driving impairment and crash risk in Parkinson disease: A systematic review and meta-analysis.
    Neurology. 2018 Aug 3. pii: WNL.0000000000006132.
    PubMed     Text format     Abstract available


    July 2018
  28. KARCESKI S
    Does deep brain stimulation help early or mild Parkinson disease?
    Neurology. 2018;91:e495-e497.
    PubMed     Text format    


  29. BRODSKY MA
    Author response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:241-242.
    PubMed     Text format    


  30. TROSTER AI
    Reader response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:240-241.
    PubMed     Text format    


  31. AZIZ TZ
    Editorialist response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:240.
    PubMed     Text format    


  32. SIDIROPOULOS C
    Reader response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:239-240.
    PubMed     Text format    


  33. KARAM C, Galetta S
    Editors' note: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:239.
    PubMed     Text format    


  34. FERRER P
    Author response: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:192.
    PubMed     Text format    


  35. BHATTACHARJEE S
    Reader response: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:191-192.
    PubMed     Text format    


  36. ALCAUSKAS M, Galetta S
    Editors' note: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:191.
    PubMed     Text format    


  37. FIRBANK MJ, Parikh J, Murphy N, Killen A, et al
    Reduced occipital GABA in Parkinson disease with visual hallucinations.
    Neurology. 2018 Jul 18. pii: WNL.0000000000006007.
    PubMed     Text format     Abstract available


  38. ONOFRJ M, Gilbert GJ
    GABA and hallucinations in Parkinson disease: Who is that sitting on my chair?
    Neurology. 2018 Jul 18. pii: WNL.0000000000005985.
    PubMed     Text format    


  39. SEARLES NIELSEN S, Racette BA
    Author response: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:104.
    PubMed     Text format    


  40. KAWADA T
    Reader response: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:104.
    PubMed     Text format    


  41. ALCAUSKAS M, Galetta S
    Editors' note: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:103.
    PubMed     Text format    


  42. NONNEKES J, Bloem BR
    Deliberate gait scissoring to overcome freezing of gait in Parkinson disease.
    Neurology. 2018;91:97.
    PubMed     Text format    


    June 2018
  43. HACKER ML, DeLong MR, Turchan M, Heusinkveld LE, et al
    Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease.
    Neurology. 2018 Jun 29. pii: WNL.0000000000005903.
    PubMed     Text format     Abstract available


  44. CORVOL JC, Artaud F, Cormier-Dequaire F, Rascol O, et al
    Longitudinal analysis of impulse control disorders in Parkinson disease.
    Neurology. 2018 Jun 20. pii: WNL.0000000000005816.
    PubMed     Text format     Abstract available


  45. DE PABLO-FERNANDEZ E, Goldacre R, Pakpoor J, Noyce AJ, et al
    Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
    Neurology. 2018 Jun 13. pii: WNL.0000000000005771.
    PubMed     Text format     Abstract available


    May 2018
  46. CHEN H
    Author response: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:941.
    PubMed     Text format    


  47. MAHLKNECHT P, Kiechl S, Willeit J, Poewe W, et al
    Reader response: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:940.
    PubMed     Text format    


  48. ALCAUSKAS M, Galetta S
    Editors' note: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:940.
    PubMed     Text format    


  49. BOOT E, Butcher NJ, Udow S, Marras C, et al
    Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.
    Neurology. 2018 May 11. pii: WNL.0000000000005660.
    PubMed     Text format     Abstract available


  50. GROSS A, Racette BA, Camacho-Soto A, Dube U, et al
    Use of medical care biases associations between Parkinson disease and other medical conditions.
    Neurology. 2018 May 9. pii: WNL.0000000000005678.
    PubMed     Text format     Abstract available


  51. PALMA JA, Mano T
    Central or peripheral autonomic dysfunction in Parkinson disease: Does it matter?
    Neurology. 2018 May 4. pii: WNL.0000000000005624.
    PubMed     Text format    


    April 2018
  52. FERREIRA JJ, Lees AJ, Poewe W, Rascol O, et al
    Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease.
    Neurology. 2018 Apr 25. pii: WNL.0000000000005557.
    PubMed     Text format     Abstract available


  53. FULLARD ME, Willis AW
    Author response: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:813.
    PubMed     Text format    


  54. BRYANT MS, Protas EJ
    Reader response: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:812.
    PubMed     Text format    


  55. KARAM C, Galetta S
    Editors' note: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:812.
    PubMed     Text format    


  56. GARDNER RC, Byers AL, Barnes DE, Li Y, et al
    Mild TBI and risk of Parkinson disease: A Chronic Effects of Neurotrauma Consortium Study.
    Neurology. 2018 Apr 18. pii: WNL.0000000000005522.
    PubMed     Text format     Abstract available


  57. ROOS E, Grotta A, Yang F, Bellocco R, et al
    Body mass index, sitting time, and risk of Parkinson disease.
    Neurology. 2018;90:e1413-e1417.
    PubMed     Text format     Abstract available


  58. KIM IY, O'Reilly EJ, Hughes KC, Gao X, et al
    Integration of risk factors for Parkinson disease in 2 large longitudinal cohorts.
    Neurology. 2018 Apr 11. pii: WNL.0000000000005473.
    PubMed     Text format     Abstract available


  59. PAGANO G, Polychronis S, Wilson H, Giordano B, et al
    Diabetes mellitus and Parkinson disease.
    Neurology. 2018 Apr 6. pii: WNL.0000000000005475.
    PubMed     Text format     Abstract available


  60. DAS RR, Unger MM
    Diabetes and Parkinson disease: A sweet spot?
    Neurology. 2018 Apr 6. pii: WNL.0000000000005470.
    PubMed     Text format    


  61. BARRETT MJ, Blair JC, Sperling SA, Smolkin ME, et al
    Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005421.
    PubMed     Text format     Abstract available


  62. KOO BB, Chow CA, Shah DR, Khan FH, et al
    Demoralization in Parkinson disease.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005425.
    PubMed     Text format     Abstract available


  63. BOHNEN NI, Teipel SJ
    Cholinergic forebrain density loss in Parkinson disease: More than just cognitive changes.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005408.
    PubMed     Text format    


    March 2018
  64. BOLLAND MJ, Avenell A, Gamble G, Grey A, et al
    Reader response: Expression of Concern: Does compensatory hyperparathyroidism predispose to ischemic stroke? Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy; An alternative to vitamin D supplementation to
    Neurology. 2018;90:627-628.
    PubMed     Text format    


  65. KARAM C, Galetta S
    Editors' note: Expression of Concern: Does compensatory hyperparathyroidism predispose to ischemic stroke? Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy; An alternative to vitamin D supplementation to p
    Neurology. 2018;90:627.
    PubMed     Text format    


  66. ROY HA, Aziz TZ, Fitzgerald JJ, Green AL, et al
    Beta oscillations and urinary voiding in Parkinson disease.
    Neurology. 2018 Mar 23. pii: WNL.0000000000005355.
    PubMed     Text format     Abstract available


  67. FRATTINI E, Monfrini E, Bitetto G, Ferrari B, et al
    Clinical Reasoning: A 75-year-old man with parkinsonism, mood depression, and weight loss.
    Neurology. 2018;90:572-575.
    PubMed     Text format    


  68. BRODSKY M, Lahna D, Pollock J, Pettersson D, et al
    Nigrosome 1 absence in de novo Parkinson disease.
    Neurology. 2018;90:522-523.
    PubMed     Text format    


    February 2018
  69. DIRKX MF, Zach H, Bloem BR, Hallett M, et al
    The nature of postural tremor in Parkinson disease.
    Neurology. 2018 Feb 23. pii: WNL.0000000000005215.
    PubMed     Text format     Abstract available


  70. HASSAN A
    No handshake agreement on postural tremor subtypes in Parkinson disease?
    Neurology. 2018 Feb 23. pii: WNL.0000000000005199.
    PubMed     Text format    


  71. PILOTTO A, Premi E, Paola Caminiti S, Presotto L, et al
    Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease.
    Neurology. 2018 Feb 16. pii: WNL.0000000000005161.
    PubMed     Text format     Abstract available


  72. WEISS D, Massano J
    Approaching adaptive control in neurostimulation for Parkinson disease: Autopilot on.
    Neurology. 2018 Feb 14. pii: WNL.0000000000005111.
    PubMed     Text format    


  73. ARLOTTI M, Marceglia S, Foffani G, Volkmann J, et al
    Eight-hours adaptive deep brain stimulation in patients with Parkinson disease.
    Neurology. 2018 Feb 14. pii: WNL.0000000000005121.
    PubMed     Text format     Abstract available


  74. HONMA M, Masaoka Y, Kuroda T, Futamura A, et al
    Impairment of cross-modality of vision and olfaction in Parkinson disease.
    Neurology. 2018 Feb 7. pii: WNL.0000000000005110.
    PubMed     Text format     Abstract available


    January 2018
  75. MURATA M, Odawara T, Hasegawa K, Iiyama S, et al
    Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized, double-blind phase 2 study.
    Neurology. 2018 Jan 24. pii: WNL.0000000000005010.
    PubMed     Text format     Abstract available


  76. HERSHEY LA, Irwin DJ
    Zonisamide for DLB parkinsonism: An old drug used in a new context.
    Neurology. 2018 Jan 24. pii: WNL.0000000000005006.
    PubMed     Text format    


  77. LEE PC, Ahmed I, Loriot MA, Mulot C, et al
    Smoking and Parkinson disease: Evidence for gene-by-smoking interactions.
    Neurology. 2018 Jan 19. pii: WNL.0000000000004953.
    PubMed     Text format     Abstract available


  78. DAVIS JL, Kurek JA, Morgan JC, Sethi KD, et al
    Teaching Video NeuroImages: Oculogyric crisis in treated Parkinson disease.
    Neurology. 2018;90:e263.
    PubMed     Text format    


  79. MUNOZ DG, Fujioka S
    Caffeine and Parkinson disease: A possible diagnostic and pathogenic breakthrough.
    Neurology. 2018 Jan 3. pii: WNL.0000000000004898.
    PubMed     Text format    


  80. FUJIMAKI M, Saiki S, Li Y, Kaga N, et al
    Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.
    Neurology. 2018 Jan 3. pii: WNL.0000000000004888.
    PubMed     Text format     Abstract available


    December 2017
  81. BARTHEL C, Nonnekes J, van Helvert M, Haan R, et al
    The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2017 Dec 20. pii: WNL.0000000000004795.
    PubMed     Text format     Abstract available


  82. ROSSO AL, Bohnen NI, Launer LJ, Aizenstein HJ, et al
    Vascular and dopaminergic contributors to mild parkinsonian signs in older adults.
    Neurology. 2017 Dec 15. pii: WNL.0000000000004842.
    PubMed     Text format     Abstract available


  83. MELE B, Holroyd-Leduc J, Smith EE, Pringsheim T, et al
    Detecting anxiety in individuals with Parkinson disease: A systematic review.
    Neurology. 2017 Dec 6. pii: WNL.0000000000004771.
    PubMed     Text format     Abstract available


  84. FERRER P, Montoya J, Garcia Ruiz PJ
    Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2017;89:e272-e273.
    PubMed     Text format    


  85. BROCKMANN K, Lerche S, Dilger SS, Stirnkorb JG, et al
    SNPs in Abeta clearance proteins: Lower CSF Abeta1-42 levels and earlier onset of dementia in PD.
    Neurology. 2017;89:2335-2340.
    PubMed     Text format     Abstract available


  86. DAHODWALA N, Shah K, He Y, Wu SS, et al
    Sex disparities in access to caregiving in Parkinson disease.
    Neurology. 2017 Dec 1. pii: WNL.0000000000004764.
    PubMed     Text format     Abstract available


    November 2017
  87. CENTI J, Freeman R, Gibbons CH, Neargarder S, et al
    Author response: Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2017;89:2122.
    PubMed     Text format    


  88. GUARALDI P, Poda R, Calandra-Buonaura G, Solieri L, et al
    Letter re: Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2017;89:2122.
    PubMed     Text format    


  89. DODEL R
    beta-Amyloid pathology and Parkinson disease.
    Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004756.
    PubMed     Text format    


  90. WHITWELL JL, Weigand SD, Duffy JR, Clark HM, et al
    Predicting clinical decline in progressive agrammatic aphasia and apraxia of speech.
    Neurology. 2017 Nov 1. pii: 10.1212/WNL.0000000000004685.
    PubMed     Text format     Abstract available


    October 2017
  91. CUMMING K, Macleod AD, Myint PK, Counsell CE, et al
    Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2017 Oct 27. pii: 10.1212/WNL.0000000000004691.
    PubMed     Text format     Abstract available


  92. MOLLENHAUER B, Caspell-Garcia CJ, Coffey CS, Taylor P, et al
    Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.
    Neurology. 2017 Oct 13. pii: 10.1212/WNL.0000000000004609.
    PubMed     Text format     Abstract available


  93. UC EY, Rizzo M, O'Shea AMJ, Anderson SW, et al
    Longitudinal decline of driving safety in Parkinson disease.
    Neurology. 2017 Oct 11. pii: 10.1212/WNL.0000000000004629.
    PubMed     Text format     Abstract available


  94. TABUAS-PEREIRA M, Santana I, Santo GC
    Clinical Reasoning: A 55-year-old man with rapidly progressive dementia and parkinsonism.
    Neurology. 2017;89:e182-e187.
    PubMed     Text format    


  95. BRODSKY MA, Anderson S, Murchison C, Seier M, et al
    Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2017 Oct 6. pii: 10.1212/WNL.0000000000004630.
    PubMed     Text format     Abstract available


  96. AZIZ TZ, Hariz M
    To sleep or not to sleep during deep brain stimulation surgery for Parkinson disease?
    Neurology. 2017 Oct 6. pii: 10.1212/WNL.0000000000004635.
    PubMed     Text format    


    September 2017
  97. LEEHEY M, Luo S, Sharma S, Wills AA, et al
    Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.
    Neurology. 2017 Sep 29. pii: 10.1212/WNL.0000000000004572.
    PubMed     Text format     Abstract available


  98. HEDERA P, Davis TL
    Can lifestyle modification slow progression of Parkinson disease?
    Neurology. 2017 Sep 29. pii: 10.1212/WNL.0000000000004580.
    PubMed     Text format    


  99. POSTUMA RB, Anang J, Pelletier A, Joseph L, et al
    Caffeine as symptomatic treatment for Parkinson disease (Cafe-PD): A randomized trial.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004568.
    PubMed     Text format     Abstract available


  100. MOREAU C, Barton BR, Devos D
    Virtually reducing fall risk in Parkinson disease.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004581.
    PubMed     Text format    


  101. MAIDAN I, Rosenberg-Katz K, Jacob Y, Giladi N, et al
    Disparate effects of training on brain activation in Parkinson disease.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004576.
    PubMed     Text format     Abstract available


  102. THORMANN A, Sorensen PS, Koch-Henriksen N, Laursen B, et al
    Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality.
    Neurology. 2017 Sep 20. pii: 10.1212/WNL.0000000000004508.
    PubMed     Text format     Abstract available


  103. SHAMIR R, Klein C, Amar D, Vollstedt EJ, et al
    Analysis of blood-based gene expression in idiopathic Parkinson disease.
    Neurology. 2017 Sep 15. pii: 10.1212/WNL.0000000000004516.
    PubMed     Text format     Abstract available


  104. LECLAIR-VISONNEAU L, Clairembault T, Coron E, Le Dily S, et al
    REM sleep behavior disorder is related to enteric neuropathology in Parkinson disease.
    Neurology. 2017 Sep 8. pii: 10.1212/WNL.0000000000004496.
    PubMed     Text format     Abstract available


  105. BOWMAN GL
    Biomarkers for early detection of Parkinson disease: A scent of consistency with olfactory dysfunction.
    Neurology. 2017 Sep 6. pii: 10.1212/WNL.0000000000004383.
    PubMed     Text format    


  106. CHEN H, Shrestha S, Huang X, Jain S, et al
    Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2017 Sep 6. pii: 10.1212/WNL.0000000000004382.
    PubMed     Text format     Abstract available


  107. SEARLES NIELSEN S, Warden MN, Camacho-Soto A, Willis AW, et al
    A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2017 Sep 1. pii: 10.1212/WNL.0000000000004536.
    PubMed     Text format     Abstract available


    August 2017
  108. FULLARD ME, Thibault DP, Hill A, Fox J, et al
    Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2017 Aug 23. pii: 10.1212/WNL.0000000000004355.
    PubMed     Text format     Abstract available


  109. NOLANO M, Provitera V, Manganelli F, Iodice R, et al
    Loss of cutaneous large and small fibers in naive and l-dopa-treated PD patients.
    Neurology. 2017;89:776-784.
    PubMed     Text format     Abstract available


  110. SHPRECHER DR, Majersik JJ
    The virtual house call: A 21st-century innovation in the care of patients with Parkinson disease.
    Neurology. 2017 Aug 16. pii: 10.1212/WNL.0000000000004366.
    PubMed     Text format    


  111. BECK CA, Beran DB, Biglan KM, Boyd CM, et al
    National randomized controlled trial of virtual house calls for Parkinson disease.
    Neurology. 2017 Aug 16. pii: 10.1212/WNL.0000000000004357.
    PubMed     Text format     Abstract available


  112. VERHAGEN METMAN L, Espay AJ
    Teaching Video NeuroImages: The underrecognized diphasic dyskinesia of Parkinson disease.
    Neurology. 2017;89:e83-e84.
    PubMed     Text format    


  113. CURY RG, Fraix V, Castrioto A, Perez Fernandez MA, et al
    Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia.
    Neurology. 2017 Aug 2. pii: 10.1212/WNL.0000000000004295.
    PubMed     Text format     Abstract available


    July 2017
  114. REGENSBURGER M, Turk M, Pagenstecher A, Schroder R, et al
    VCP-related multisystem proteinopathy presenting as early-onset Parkinson disease.
    Neurology. 2017 Jul 19. pii: 10.1212/WNL.0000000000004240.
    PubMed     Text format    


  115. IRANZO A, Stefani A, Serradell M, Marti MJ, et al
    Characterization of patients with longstanding idiopathic REM sleep behavior disorder.
    Neurology. 2017;89:242-248.
    PubMed     Text format     Abstract available


  116. JACOVA C, Factor SA
    Phosphodiesterase 4: Rethinking cognition in Parkinson disease.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004221.
    PubMed     Text format    


  117. NICCOLINI F, Wilson H, Pagano G, Coello C, et al
    Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004201.
    PubMed     Text format     Abstract available


  118. SIERRA M, Martinez-Rodriguez I, Sanchez-Juan P, Gonzalez-Aramburu I, et al
    Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004185.
    PubMed     Text format     Abstract available


  119. CILIA R, Laguna J, Cassani E, Cereda E, et al
    Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004175.
    PubMed     Text format     Abstract available



  120. Decrease in Abeta42 predicts dopa-resistant gait progression in early Parkinson disease.
    Neurology. 2017;89:107.
    PubMed     Text format    


    June 2017
  121. HUGHES KC, Gao X, Kim IY, Wang M, et al
    Intake of dairy foods and risk of Parkinson disease.
    Neurology. 2017 Jun 8. pii: 10.1212/WNL.0000000000004057.
    PubMed     Text format     Abstract available


  122. RAJPUT AH, Rajput ML, Ferguson LW, Rajput A, et al
    Baseline motor findings and Parkinson disease prognostic subtypes.
    Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004078.
    PubMed     Text format     Abstract available


    May 2017
  123. MARKOVIC V, Agosta F, Canu E, Inuggi A, et al
    Role of habenula and amygdala dysfunction in Parkinson disease patients with punding.
    Neurology. 2017 May 10. pii: 10.1212/WNL.0000000000004012.
    PubMed     Text format     Abstract available


  124. STOCCHI F, Rascol O, Hauser RA, Huyck S, et al
    Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease.
    Neurology. 2017 May 10. pii: 10.1212/WNL.0000000000004003.
    PubMed     Text format     Abstract available


    April 2017
  125. LIU B, Fang F, Pedersen NL, Tillander A, et al
    Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study.
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003961.
    PubMed     Text format     Abstract available


  126. BORGHAMMER P, Hamani C
    Preventing Parkinson disease by vagotomy: Fact or fiction?
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003969.
    PubMed     Text format    


    March 2017
  127. PAKPOOR J, Noyce A, Goldacre R, Selkihova M, et al
    Viral hepatitis and Parkinson disease: A national record-linkage study.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003848.
    PubMed     Text format     Abstract available


  128. BENITO-LEON J
    Viral hepatitis and the risk of Parkinson disease.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003853.
    PubMed     Text format    


  129. ROCHESTER L, Galna B, Lord S, Yarnall AJ, et al
    Decrease in Abeta42 predicts dopa-resistant gait progression in early Parkinson disease.
    Neurology. 2017 Mar 22. pii: 10.1212/WNL.0000000000003840.
    PubMed     Text format     Abstract available


  130. SINGER W, Berini SE, Sandroni P, Fealey RD, et al
    Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
    Neurology. 2017;88:1129-1136.
    PubMed     Text format     Abstract available


  131. NONNEKES J, Janssen S, Bloem BR
    Superficial brain stimulation to overcome freezing of gait in Parkinson disease.
    Neurology. 2017 Mar 15. pii: 10.1212/WNL.0000000000003859.
    PubMed     Text format    


  132. SAARI L, Kivinen K, Gardberg M, Joutsa J, et al
    Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003810.
    PubMed     Text format     Abstract available


    February 2017
  133. BUCHMAN AS, Bennett DA
    Author response: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:920.
    PubMed     Text format    


  134. BOHNEN NI, Muller M
    Letter re: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:920.
    PubMed     Text format    


  135. BUCHMAN AS, Bennett DA
    Author response: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:919-920.
    PubMed     Text format    


  136. MAHLKNECHT P, Kiechl S, Willeit J, Poewe W, et al
    Letter re: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:919.
    PubMed     Text format    


  137. GOLDMAN JG, Bledsoe IO, Merkitch D, Dinh V, et al
    Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease.
    Neurology. 2017 Feb 24. pii: 10.1212/WNL.0000000000003764.
    PubMed     Text format     Abstract available


  138. MERY VP, Gros P, Lafontaine AL, Robinson A, et al
    Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea.
    Neurology. 2017 Feb 22. pii: 10.1212/WNL.0000000000003738.
    PubMed     Text format     Abstract available


  139. LEWITT PA, Li J, Lu M, Guo L, et al
    Metabolomic biomarkers as strong correlates of Parkinson disease progression.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003663.
    PubMed     Text format     Abstract available


  140. ALVES G, Bonanni L
    Neurofilament light: A heavyweight diagnostic biomarker in neurodegenerative parkinsonism?
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003699.
    PubMed     Text format    


  141. HANSSON O, Janelidze S, Hall S, Magdalinou N, et al
    Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003680.
    PubMed     Text format     Abstract available


    January 2017
  142. EWENCZYK C, Mesmoudi S, Gallea C, Welter ML, et al
    Antisaccades in Parkinson disease: A new marker of postural control?
    Neurology. 2017 Jan 27. pii: 10.1212/WNL.0000000000003658.
    PubMed     Text format     Abstract available


  143. PEDERSEN KF, Larsen JP, Tysnes OB, Alves G, et al
    Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Neurology. 2017 Jan 20. pii: 10.1212/WNL.0000000000003634.
    PubMed     Text format     Abstract available


  144. FEDOROVA TD, Seidelin LB, Knudsen K, Schacht AC, et al
    Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study.
    Neurology. 2017 Jan 18. pii: 10.1212/WNL.0000000000003633.
    PubMed     Text format     Abstract available


  145. KUBU CS, Cooper SE, Machado A, Frazier T, et al
    Insights gleaned by measuring patients' stated goals for DBS: More than tremor.
    Neurology. 2017;88:124-130.
    PubMed     Text format     Abstract available


    December 2016
  146. RACETTE BA, Searles Nielsen S, Criswell SR, Sheppard L, et al
    Dose-dependent progression of parkinsonism in manganese-exposed welders.
    Neurology. 2016 Dec 28. pii: 10.1212/WNL.0000000000003533.
    PubMed     Text format     Abstract available


  147. RATNER MH, Fitzgerald E
    Understanding of the role of manganese in parkinsonism and Parkinson disease.
    Neurology. 2016 Dec 28. pii: 10.1212/WNL.0000000000003543.
    PubMed     Text format    


  148. THOLFSEN LK, Larsen JP, Schulz J, Tysnes OB, et al
    Changes in insomnia subtypes in early Parkinson disease.
    Neurology. 2016 Dec 16. pii: 10.1212/WNL.0000000000003540.
    PubMed     Text format     Abstract available


    November 2016
  149. CENTI J, Freeman R, Gibbons CH, Neargarder S, et al
    Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003452.
    PubMed     Text format     Abstract available


  150. BOYLAN LS, Messinis L
    Orthostatic hypotension, cognition, and Parkinson disease: Dumbing down by standing up.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003468.
    PubMed     Text format    


  151. MANO T, Britton Z, Britton T
    Anatomo-functional basis of nonmotor symptoms in Parkinson disease.
    Neurology. 2016 Nov 16. pii: 10.1212/WNL.0000000000003443.
    PubMed     Text format    


  152. PYATIGORSKAYA N, Mongin M, Valabregue R, Yahia-Cherif L, et al
    Medulla oblongata damage and cardiac autonomic dysfunction in Parkinson disease.
    Neurology. 2016 Nov 11. pii: 10.1212/WNL.0000000000003426.
    PubMed     Text format     Abstract available


  153. PAGANO G, Molloy S, Bain PG, Rabiner EA, et al
    Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease.
    Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003396.
    PubMed     Text format     Abstract available


    October 2016
  154. MATTIS PJ, Niethammer M, Sako W, Tang CC, et al
    Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003285.
    PubMed     Text format     Abstract available


  155. BRYS M, Fox MD, Agarwal S, Biagioni M, et al
    Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: A randomized trial.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003279.
    PubMed     Text format     Abstract available


    September 2016
  156. UMEMOTO G, Fujioka S, Yanamoto S, Fukae J, et al
    A case of sudden deterioration in Parkinson disease.
    Neurology. 2016;87:1422.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: